UniProtKB/SwissProt variant VAR

Variant information

Variant position:

158

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

Disease [Disclaimer]

The variants are classified into three categories: Disease, Polymorphism and Unclassified.

Disease: Variants implicated in disease according to literature reports.
Polymorphism: Variants not reported to be implicated in disease.
Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:

From Asparagine (N) to Aspartate (D) at position 158 (N158D, p.Asn158Asp).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and polar (N) to medium size and acidic (D)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In 3KTD; loss of acetyl-CoA C-acyltransferase activity; no degradative/thiolase activity.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs148639841 [ dbSNP | Ensembl ]

Sequence information

Variant position:

158

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

427

The length of the canonical sequence.

Location on the sequence:

QSLMCGHQDVMVAGGMESMS N VPYVMNRGSTPYGGVKLEDL

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         QSLMCGHQDVMVAGGMESMSNVPYVM--NRGSTPYGGVKLEDL

Mouse                         QSLMCGHQDVMVAGGMESMSNVPYVM--SRGATPYGGVKLE

Rat                           QSLMCGHQDVMVAGGMESMSNVPYVM--SRGATPYGGVKLE

Bovine                        QNLMCGHQDVMVAGGMESMSNVPYVM--NRGATPYGGVKLE

Xenopus tropicalis            QSLMCGHQQVMVAGGMESMSNVPYCM--SRGATPYGGVKLE

Zebrafish                     QSLMCGHQDVMVAGGMESMSQVPYIM--AREAPPYGGVKME

Baker's yeast                 QSIKCGNADVVVAGGCESMTNAPYYMPAARAGAKFGQTVLV

Fission yeast                 QTIMTGNAEIVVAGGTESMSNAPYYAPKNRFGAKYGNVELV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	34 – 427	Acetyl-CoA acetyltransferase, mitochondrial
Modified residue	174 – 174	N6-acetyllysine; alternate
Modified residue	174 – 174	N6-succinyllysine; alternate
Alternative sequence	146 – 162	DVMVAGGMESMSNVPYV -> IKQETGSLAKICCHVRR. In isoform 2.
Helix	156 – 158

Literature citations

Molecular, biochemical, and clinical characterization of mitochondrial acetoacetyl-coenzyme A thiolase deficiency in two further patients.
Wakazono A.; Fukao T.; Yamaguchi S.; Hori T.; Orii T.; Lambert M.; Mitchell G.A.; Lee G.W.; Hashimoto T.;
Hum. Mutat. 5:34-42(1995)
Cited for: VARIANTS 3KTD ASP-158; MET-297 AND PRO-301; CHARACTERIZATION OF VARIANTS 3KTD ASP-158; MET-297 AND PRO-301; FUNCTION; CATALYTIC ACTIVITY; PATHWAY;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P24752: Variant p.Asn158Asp